News Headlines Article

Value of U.S. Cancer Care Questioned
HealthLeaders Media

U.S. spending on cancer care has been increasing more steeply and expensively compared to spending in Western Europe in recent decades, but without a corresponding decrease in cancer deaths, research published in Health Affairs finds. The finding raises questions about whether the U.S. is getting its money’s worth for patients being treated for cancer.

Samir Soneji, PhD, assistant professor at the Dartmouth Institute for Health Policy and Clinical Practice based his report on an analysis of data from the World Health Organization’s Cancer Mortality database between 1982 and 2010 for 12 common types of cancer.